Diane-35 0,035 mg/2,0 mg Coated tablets
PDF Leaflet Revision Date: 21 July 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Moderate to severe acne and/or hirsutism in women of reproductive age.
Dosage (summary)
One tablet daily for 28 days; start on day 1 of menstrual cycle or after previous hormonal contraceptive.
Onset of Action / Duration
Onset: 3 months, Duration: Continuous use recommended.
Special Populations
- Obesity
- Hypertension
- Migraine
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Phenytoin
- Rifampicin
- St. John's wort
Contraindications
- Venous thrombosis
- Arterial thrombosis
- Severe hepatic disease
- Known or suspected pregnancy
Common side effects
- Nausea
- Headache
- Depressed mood
- Breast tenderness
Counselling Points
- Take at the same time daily
- Use barrier contraception during first 14 days
- Report mood changes
Serious warnings
- Increased risk of venous thromboembolism
- Monitor for signs of thrombosis
- May exacerbate migraine
Important Disclaimer
The Diane-35 0,035 mg/2,0 mg Coated tablets professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
